Skin Care

Targeting Adult Acne

Deck: 
A proper diagnosis and multidimensional treatment approach are the keys to effectively treating adult acne patients.
Main Image: 
Woman with Mask

While the general public may envision the typical acne patient as a pimple-ridden adolescent, dermatologists and estheticians know that one of the largest populations seeking treatment for acne is adults. The typical adult acne patient is a woman in her late 20s to late 40s. She may or may not have been troubled by acne in her teens, but is now experiencing breakouts, particularly along the jaw line, lower cheeks and upper neck area. The severity of adult acne breakouts varies from patient to patient and, in women, the outbreaks tend to wax and wane in conjunction with the menstrual cycle.

Article free tagging: 
Articles: 

Biologic Response

FDA-approved LaViv may offer long-lasting wrinkle relief, but will patients pay to wait six months or more for unknown results?
LaViv

When the United States Food & Drug Administration (www.fda.gov) cleared LaViv (azficel-T, Fibrocell Science, www.fibrocellscience.com) in June 2011 for the treatment of moderate to severe nasolabial folds, it was hailed as a more natural alternative to Botox. Unlike neuromodulators or hyaluronic acid-based dermal fillers, LaViv does not offer instant relief from wrinkles. Its effects depend on a biologic process. The physician extracts skin cells from behind the patient’s ear.

Getting Better with Age

Efficacy and evolving formulations have made retinoids a cornerstone of acne and antiaging care for more than 40 years.

Retinoids burst onto the scene in 1969, literally inflaming patients as a powerful new tool to wipe out acne. Now in their 40s and buffered by anti-inflammatory ingredients, new delivery systems and a greater understanding of what it takes to achieve efficacy, these ubiquitious, vitamin A-based active ingredients are more popular than ever for an expanding array of indications.

Battling the Red Menace

Galderma reports positive top-line results from its Phase 2b trial of a novel medication to treat the redness of rosacea.
Patient with Rosacea

In late October 2011, Galderma Pharma S.A. (www.galderma.com) announced top-line results from its Phase 2b trial of CD07805/47 gel 0.5%, the company’s proprietary brimonidine tartrate formulation. The results confirm the gel’s potential to become a viable topical treatment option for the persistent facial redness of rosacea. If approved, the formulation could provide an alternative to laser and IPL treatments currently considered the gold standard in addressing rosacea-related redness and telangectasia.

Eating for Beautiful Skin

Though most doctors—and patients—believe that a healthy lifestyle can improve skin texture and tone and reduce the signs of aging, there has not been an abundance of skincare-specific proof. A new study may change that. In “An Encapsulated Fruit and Vegetable Concentrate Increases Skin Microcirculation in Healthy Woman,” which will be published in the Journal of Skin Pharmacology and Physiology (Vol. 25, No.

Focus on PDT

Photodynamic therapy has surged in popularity over the past 20 years as a treatment for photodamaged skin cells, pilosebaceous disorders, nonmelanoma skin cancers and general facial rejuvenation. In Photodynamic Therapy in Dermatology—published by Springer and edited by Michael Gold, MD, Gold Skin Care Center and clinical assistant professor of dermatology at Vanderbilt University School of Medicine in Nashville, Tennessee—Dr.

Volume Matters

Deck: 
How dermal fillers are reshaping cosmetic medicine
Main Image: 
Volume Matters

By Wendy Lewis

Dermal fillers have become a popular tool to address contour defects that are the inevitable result of aging. The effectiveness, low morbidity and predictable, reproducible results of these treatments have made dermal fillers the bread and butter of most cosmetic practices.
Additionally, “We now have a range of dermal fillers that are useful to fill an isolated wrinkle, and fillers that can be injected into multiple tissue planes to create a change in facial shape and restore volume,” says New York City-based plastic surgeon Bryan G. Forley, MD, FACS.

Article free tagging: 
Articles: 

Spot Treatment

Deck: 
A new generation of homecare formulations aims to improve long-term hyperpigmentation treatment outcomes.
Main Image: 
Spot treatment

Hyperpigmentation is one of the most widespread conditions seen in medical aesthetic practices and it affects patients of all skin types and ages. Effective treatments have traditionally shared one major drawback: the risk of rebound or post-inflammatory hyperpigmentation. Today, formulators and physicians are seeking ways to match the efficacy of existing treatments while providing long-term benefits.

Articles: 

Periorbital Revolution

Deck: 
The scalpel is no longer the only weapon to fight the signs of periorbital aging
Main Image: 

Crow’s feet and glabellar furrows dig in for the siege. Dispigmentation, unsightly veins and dark undereye circles take up offensive positions. Then the truly frightening enemies start their advance. Brows and lashes thin and fade; lids get heavier and begin to sag; bags develop under the eyes; and the surrounding skin becomes thin and crepey. Most women begin to camouflage these flaws long before they’re ready for blepharoplasty. Even those who would never consider cosmetic surgery happily spend whatever they can afford to defend themselves against these distressing signs of aging.